Giulia De Rossi
London, ENG EC1V9EL, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in mice.
Journal: Science translational medicine
Published: October 22, 2025
LRG1 Alters Pericyte Phenotype and Compromises Vascular Maturation.
Journal: Cells
Published: February 09, 2025
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degeneration.
Journal: British journal of pharmacology
Published: June 26, 2024
Functional Changes Within the Rod Inner Segment Ellipsoid in Wildtype Mice: An Optical Coherence Tomography and Electron Microscopy Study.
Journal: Investigative ophthalmology & visual science
Published: July 11, 2022
Correction: LRG1 as a novel therapeutic target in eye disease.
Journal: Eye (London, England)
Published: March 01, 2022
Structural basis of human LRG1 recognition by Magacizumab, a humanized monoclonal antibody with therapeutic potential.
Journal: Acta crystallographica. Section D, Structural biology
Published: November 24, 2021
LRG1: an emerging player in disease pathogenesis.
Journal: Journal of biomedical science
Published: October 16, 2021
LRG1 as a novel therapeutic target in eye disease.
Journal: Eye (London, England)
Published: September 09, 2021
CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Journal: American journal of respiratory and critical care medicine
Published: March 30, 2021
Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin Internalization.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: February 18, 2021
Last Updated: 09/26/2026